Blog
RSS FeedPosted by Michael Wonder on 12 Oct 2017
Missing out on cancer drugs
12 October 2017 - A letter to the Editor of the New Zealand Herald from the Managing Director of MSD ...
Posted by Michael Wonder on 12 Oct 2017
New treatment option for people with gastro-intestinal cancer
12 October 2017 - More people will be able to receive regorafenib now that NICE has said it should move out ...
Posted by Michael Wonder on 12 Oct 2017
Health fund premiums to be reined in under sweeping Turnbull government changes
12 October 2017 - Private health insurers will be able to charge higher excesses and offer discounts to under-30s under ...
Posted by Michael Wonder on 11 Oct 2017
CDR Update — Issue 129
11 October 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the resubmission ...
Posted by Michael Wonder on 11 Oct 2017
Study finds significant overlap in the drugs covered by Canadian public drug plans
11 October 2017 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilisation Information System research initiative, ...
Posted by Michael Wonder on 11 Oct 2017
Xeljanz receives positive reimbursement decision in England
11 October 2017 - The UK’s HTA body NICE has provided final guidance recommending Xeljanz (tofacitinib citrate) as a treatment ...
Posted by Michael Wonder on 11 Oct 2017
Obesity related diseases expected to cost Australia $21 billion
11 October 2017 - Without action on obesity, the economic burden of treating obesity related diseases is estimated to rise from ...
Posted by Michael Wonder on 10 Oct 2017
Agenda for 11 October TC meeting
9 October 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 09 Oct 2017
Patients in Scotland first to get new blood cancer drug daratumumab on NHS
9 October 2017 - An innovative new drug for the treatment of a complex blood cancer has been approved for ...
Posted by Michael Wonder on 09 Oct 2017
SMC - October 2017 decisions
9 October 2017 - SMC accepts medicines for hepatitis C and multiple myeloma for use by NHSScotland. ...
Posted by Michael Wonder on 09 Oct 2017
Private patients foot the bill for health insurance rebate cuts
9 October 2017 - Labor’s changes to the health insurance rebate meant federal government spending on the subsidy dropped for ...
Posted by Michael Wonder on 09 Oct 2017
PBS listing opens up a new medication era for leukaemia patients
9 October 2017 - The Leukaemia Foundation welcomes the Federal Government’s announcement today that the cancer medicine, Imbruvica (ibrutinib) will ...
Posted by Michael Wonder on 09 Oct 2017
Time for a change in how new antibiotics are reimbursed: development of an insurance framework for funding new antibiotics based on a policy of risk mitigation
9 October 2017 - Healthcare systems depend on the availability of new antibiotics. ...
Posted by Michael Wonder on 08 Oct 2017
Supercharged Gardasil cervical cancer vaccine provides extra protection for teens
7 October 2017 - A supercharged vaccine that protects against several deadly cancers will be provided for free to all ...
Posted by Michael Wonder on 08 Oct 2017
Turnbull government subsidy gives hope to cancer sufferers
9 October 2017 - A breakthrough leukaemia and lymphoma drug that normally costs $187,000 per treatment will become easily affordable ...